Filing Details
- Accession Number:
- 0000899243-20-030992
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-13 16:20:28
- Reporting Period:
- 2020-11-11
- Accepted Time:
- 2020-11-13 16:20:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1490978 | Schrodinger Inc. | SDGR | Pharmaceutical Preparations (2834) | 954284541 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1798179 | Lorne Robert Abel | C/O Schrodinger, Inc., 120 West 45Th Street, 17Th Floor New York NY | Evp, Science | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-11 | 10,032 | $4.34 | 63,541 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-11-11 | 5,841 | $3.07 | 69,382 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-11 | 29,577 | $49.56 | 39,805 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-11 | 13,050 | $50.59 | 26,755 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-11-11 | 10,032 | $0.00 | 10,032 | $4.34 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-11-11 | 5,841 | $0.00 | 5,841 | $3.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,722 | 2028-11-29 | No | 4 | M | Direct | |
| 14,224 | 2026-05-10 | No | 4 | M | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2020.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.09 to $50.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.09 to $51.025, inclusive.
- The option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022.
- The option was granted on May 11, 2016 and is fully vested.
Billionaire Hedge Funds
